NEWSROOM
Discover all the actions carried out by Jeito and all the partnerships that we set up day after day for the well-being of patients and medical progress.
In the headlines
Jeito Capital co-leads €164.5 million ($181.4 million) oversubscribed Series D financing in Alentis Therapeutics to advance clinical development of Anti-Claudin-1 (CLDN1) ADCs in solid tumors
Building on its co-lead investments in Alentis Therapeutics’ Series B (2021) and Series C (2023) rounds, Jeito’s renewed commitment demonstrates its strategy of supporting promising portfolio companies through key value-creation milestones. Financing will advance...
Download our White Paper
We are pleased to share with you our White Paper, which offers a deep dive into the evolving biopharma landscape and highlights the key trends shaping its future.
Find all our press releases
NMD Pharma Reports Positive Top-Line Data from a Phase I/IIa Clinical Trial of NMD670 in Patients with Myasthenia Gravis
Aarhus, Denmark, 11 October 2022 - NMD Pharma A/S, a clinical stage biotech company developing...
Jeito Capital co-leads €75 million Series B financing in SparingVision
Paris, France, September 14, 2022 - Jeito Capital ("Jeito"), a leading independent Private Equity...
Jeito Capital co-leads $76 million Series A financing for CDR-Life its 10th investment since its launch
Paris, France, April 13, 2022 - Jeito Capital ("Jeito"), a leading independent Private Equity firm...
Jeito Capital co-leads EUR 80 million euro Series B financing in European oncology company, Precirix
Paris, France, March 2022, 16th – Jeito Capital (“Jeito”), a leading independent private equity...
Jeito Capital co-leads $65 million Series A financing in EyeBio
Paris, France, 22 February 2022 – Jeito Capital (“Jeito”), a leading independent private equity...
Jeito Capital announces the appointments of Dr Andreas Wallnoefer as Partner Investor and Isabelle Meyrier as Head of Legal
Paris, France, February 17, 2022 - Jeito Capital ("Jeito"), a leading independent private equity...
Face to face
Meet Jeito
16-17
December
All day long
Conference of Paris 2024
Jeito will be present at the Conference of Paris 2024, for its 8th edition around the theme “Confronting the Unknown”, encouraging leaders to share their knowledge and understanding of global economic, social and environmental issues as a way to collaborate and collectively overcome these challenges.
13-16
January
All day long
JPM Healthcare Conference 2025
Jeito will be present at the 43rd JPM Healthcare Conference 2025, renowned as the largest and most influential healthcare investment symposium, attracting global industry leaders, Biotech companies, and members of the investment community, in San Francisco.
28-30
January
All day long
IPEM Cannes 2025
Jeito will be present at the 11th edition of IPEM Cannes – Wealth 2025, gathering Private Capital key decision-makers and incubating this year “IPEM Wealth”, a brand-new format designed to support the democratization of Private Markets, in Cannes.